TRAW
NASDAQ
$0.61
Traws Pharma Inc (TRAW)
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. The company is headquartered in Newtown, Pennsylvania.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $1 (+63.75%)
Market Cap
$9.16M
Revenue 5Y CAGR
+51.20%
Beta (5Y)
1.18
Price Chart
Valuation
Market Cap$9.16M
P/S4.77
P/B2.16
Profitability
Total Revenue (TTM)$2.79M
Gross Profit (TTM)$2.73M
EBITDA-$12M
Operating Margin-718%
EPS-$1.99
Growth & Risk
Revenue 5Y CAGR+51.20%
FCF 5Y CAGR-4.58%
Beta (5Y)1.18
Sharpe Ratio-0.12